Coverage dated December 3, 2021 to December 8, 2021
Elizabeth Holmes' defense rests its case
Headline from Local News 8, on the newest of 2 developments
By Sara Ashley O’Brien, CNN Business Elizabeth Holmes’ defense rested its case Wednesday, shortly after the founder and former CEO of Theranos concluded her seventh day on the witness stand in her own criminal trial.
Local News 8's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Theranos founder Elizabeth Holmes faces cross-examination
For months, jurors at Elizabeth Holmes' criminal trial have heard one witness after another speak about the confident and charismatic former CEO of Theranos. Witnesses testified about how she convinced investors to pour hundreds of millions of dollars into her failed blood-testing startup, attracted…
SAN FRANCISCO (AP) — The fraud trial of fallen Theranos founder Elizabeth Holmes is set to resume Tuesday with continued cross-examination of Holmes and possible expert psychological testimony.
Elizabeth Holmes’s surprise turn on the witness stand in her criminal-fraud trial has given jurors a close look at the control she held over her blood-testing startup Theranos Inc., and at the alleged torment she endured in her personal life at the same time.
SAN JOSE, Calif. (AP) — Defense lawyers in the criminal fraud trial of fallen entrepreneur Elizabeth Holmes rested their case Wednesday, setting up several days of checking juror schedules and figurin
By Sara Ashley O’Brien, CNN Business Elizabeth Holmes’ defense rested its case Wednesday, shortly after the founder and former CEO of Theranos concluded her seventh day on the witness stand in her own criminal trial.
After seven days, Elizabeth Holmes was her own final witness in her defense against federal fraud charges tied to her failed blood-testing startup as testimony